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Non-Invasive Placental Perfusion 
Imaging in Pregnancies 
Complicated by Fetal Heart Disease 
Using Velocity-Selective Arterial 
Spin Labeled MRI
Zungho Zun1,2,3,4, Greg Zaharchuk5, Nickie N. Andescavage3,6, Mary T. Donofrio2,3,7 & 
Catherine Limperopoulos1,2,3,4
The placenta is a vital organ for fetal growth and development during pregnancy. Congenital 
heart disease (CHD) is a leading cause of morbidity and mortality in newborns. Despite the parallel 
development of the placenta and fetal heart early in pregnancy, very few studies suggested an 
association between placental dysfunction and fetal CHD. In this study, we report placental perfusion 
of healthy pregnancies and pregnancies complicated by fetal CHD measured using advanced fetal MRI 
techniques. We studied forty-eight pregnant women (31 healthy volunteers and 17 with fetal CHD) 
that underwent fetal MRI during their second or third trimester of pregnancy. Placental perfusion 
imaging was performed using velocity-selective arterial spin labeling (VSASL) and 3D image acquisition 
with whole-placenta coverage. In pregnancies with fetal CHD, global placental perfusion significantly 
decreased and regional variation of placental perfusion significantly increased with advancing 
gestational age; however, no such correlation was found in healthy pregnancies. Also, global placental 
perfusion was significantly higher in fetal CHD versus controls, in the lateral side-lying patient position 
versus supine, and in the posterior placental position versus anterior placental position. This study 
reports for the first time non-invasive whole-placenta perfusion imaging in utero. These data suggest 
that placental VSASL may serve as a potential biomarker of placental dysfunction in fetuses diagnosed 
with CHD.
The placenta is a vital organ that provides oxygen and nutrients, discharges wastes, and serves as an immune 
barrier for fetal well-being during pregnancy. Early in pregnancy, remodeling of the spiral arteries develops such 
that blood flow in the maternal-placental circulation increases in order to support rapid fetal growth and develop-
ment1. When this remodeling fails, placental insufficiency occurs where oxygen and nutrients are not adequately 
supplied to the fetus through the feto-placental circulation1–4. While placental insufficiency is known to often 
result in fetal growth restriction (FGR)1,2 or preeclampsia3,4, the relationship between placental function and 
congenital heart disease (CHD) in fetuses is largely unknown. Despite the parallel development of the placenta 
and fetal heart early in pregnancy, very few studies have highlighted an association between the placenta and fetal 
CHD5–9. Notably, impaired placental growth in CHD has been shown to be associated with gestational age (GA) 
and birth weight at delivery, suggesting that abnormalities in placental development may contribute to increased 
morbidity in this high-risk population8. The vascular density, vascular area, and the number of terminal villi 
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of the placenta have also been reported to be small in CHD based on placental pathology after delivery9. The 
vascular function of the placenta during pregnancy, however, is poorly understood namely due to the absence of 
non-invasive tools for measuring and monitoring placental function in utero.
Arterial spin labeling (ASL) is a powerful MRI technique for the direct, quantitative measures of regional 
tissue perfusion and has been extensively applied to the brain10. Unlike conventional perfusion MRI techniques, 
ASL does not require contrast agents because it utilizes the water molecules in arterial blood as an endogenous 
contrast agent. ASL is a particularly attractive method for early and safe monitoring during pregnancy given that 
ASL is completely non-invasive and does not require contrast agents or exposure to ionizing radiation. In addi-
tion, ASL provides reliable quantitative measurement, which enables comparison of absolute perfusion between 
different patients. To date, only two groups have applied ASL to the placenta and demonstrated limited ASL image 
quality and imaging coverage; this may be largely due to technical limitations of the labeling paradigm used in 
their studies11–14. No study has examined placental perfusion in fetuses diagnosed with CHD using ASL.
In this study, we used a novel placental perfusion imaging technique described by our group using 
velocity-selective ASL (VSASL) and 3D image acquisition to achieve higher sensitivity to placental perfusion and 
increased signal-to-noise ratio (SNR)15. VSASL allows for the labeling of all flowing arterial spins with a specific 
range of velocity, regardless of location16,17. Using VSASL, we measured total placenta perfusion that includes 
both maternal and fetal contributions. We quantified both global perfusion and regional perfusion variation in 
the placenta of pregnancies complicated by fetal CHD and healthy controls in order to determine whether placen-
tal perfusion alterations are evident in utero in the setting of fetal CHD.
Results
Study population. Among 50 pregnant women that we recruited, one pregnant woman complicated by 
fetal CHD and one healthy pregnant woman were excluded due to severe motion artifacts. Table 1 summarizes 
the baseline characteristics of our remaining study cohort (31 fetal CHD, 17 controls). The primary diagnosis for 
fetal CHD was used. Three out of 17 (18%) pregnant women with fetal CHD and 4 out of 31 (13%) healthy preg-
nant women received a second, follow-up fetal MRI scan using the same scan protocol. There was no significant 
difference in GA, maternal age, and fetal sex between CHD and healthy control fetuses. There were no maternal 
conditions in our study population except for one pregnant woman with fetal CHD who had gestational diabetes.
Global placental perfusion measures. Global placental perfusion, which we define as the mean placental 
perfusion of all voxels within the placenta of each subject, was found to be 236 ± 88 ml/100 g/min in pregnancies 
with fetal CHD and 188 ± 40 ml/100 g/min in healthy pregnancies (p = 0.10). As shown in Fig. 1, there was a 
substantially larger variation of perfusion in pregnancies with fetal CHD. After controlling for GA, global placen-
tal perfusion was significantly higher in CHD versus control placentas (p < 0.01). Interestingly, plotting global 
placental perfusion and GA revealed different global perfusion characteristics in pregnancies with CHD versus 
controls. Figure 2a shows a scatter plot of global placental perfusion and GA (excluding the data from the second 
fetal MRI). While healthy controls showed no significant correlation between global placental perfusion and GA 
(r = −0.16, p = 0.40), pregnant women with fetal CHD demonstrated a significant negative correlation between 
global perfusion and GA (r = −0.67, p < 0.01). Furthermore, data from 7 subjects (3 CHD and 4 controls) who 
underwent fetal MRI scans twice are displayed in Fig. 2b. The interval between the first and second fetal MRI 
scans was 5, 5, and 9 weeks for the three fetuses with CHD, and was 4, 6, 9, and 10 weeks for the four controls. 
The slope between the two data points within each subject was −18.2, −17.0, and −12.0 for CHD and −1.3, 
−3.0, −2.7, and 0.5 for controls (all in unit of ml/100 g/min/week). These were similar to the slope of the linear 
regression line in each group, which was −11.8 and −1.1 ml/100 g/min/week for CHD and controls respectively. 
The CHD diagnoses of these three subjects were as follows: two hypoplastic left heart syndrome (HLHS) and one 
tetralogy of Fallot (TOF).
Relationship between placental perfusion and i) patient position during the fetal MRI and ii) 
position of the placenta. We compared global placental perfusion in relationship to patient position 
Characteristics CHD (n = 17) Controls (n = 31) p-value
Gestational age at MRI (weeks) 32 ± 5 (22–38) 30 ± 5 (21–39) 0.36
Maternal age (years) 33 ± 5 (23–43) 34 ± 4 (26–41) 0.70
Male fetuses 10 (59%) 14 (45%) 0.37
Subjects with two MRI scans 3 (18%) 4 (13%)
Primary CHD diagnosis
  Hypoplastic left heart syndrome 7 (41%)
  Tetralogy of Fallot 3 (18%)
  Ventricular septal defect 2 (12%)
  Truncus Arteriosus 2 (12%)
  Double-outlet right ventricle 1 (6%)
  D-Transposition of the great arteries 1 (6%)
  Total anomalous pulmonary venous return 1 (6%)
Table 1. Characteristics of our study cohort (n = 48). The p-values were estimated based on a Wilcoxon rank-
sum test for GA and maternal age, and a chi-squared test for fetal sex.
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during the fetal MRI (see Fig. 3) given that the gravid uterus may reduce placental perfusion in the supine posi-
tion18. In our data, 14 out of 17 pregnant women with fetal CHD (82%) and 15 out of 31 healthy pregnant women 
(48%) were scanned in the lateral side-lying position while the remaining pregnant women were scanned in the 
supine position. In pregnancies complicated by fetal CHD, global placental perfusion acquired in the lateral posi-
tion showed a significant correlation with GA (r = −0.61, p = 0.02). This is similar to the result from overall fetal 
CHD data of lateral and supine positions because the difference in sample size was only three. Healthy controls, 
however, were divided almost equally into data acquired in the lateral (n = 15) and supine (n = 16) positions. 
While global placental perfusion of the healthy controls acquired in the lateral position was relatively consistent 
across GA (r = −0.09, p = 0.74), healthy controls studied in the supine position showed a negative trend in global 
placental perfusion with advancing GA (r = −0.43, p = 0.09). Mean global placental perfusion of healthy controls 
studied in the lateral and supine positions were 207 ± 39 ml/100 g/min and 171 ± 32 ml/100 g/min, respectively 
(p < 0.01 controlling for GA). Furthermore, we divided the subjects based on their position of the placenta in 
the uterus (anterior or posterior). For fetal CHD, 10 out of 14 women that were studied in the lateral position 
had an anterior placenta (71%), and 2 out of 3 women that were studied in the supine position had an anterior 
placenta (67%). The healthy pregnant women that were studied in the lateral and supine patient positions were 
both divided into anterior and posterior placental position almost equally (8 anterior vs 7 posterior for lateral, 8 
anterior vs 8 posterior for supine). Because the sample size was small and unbalanced in fetal CHD, we focused on 
healthy controls for further analysis. Using multiple linear regression analysis (independent variables: GA, patient 
position, placental position), global placental perfusion of healthy controls was found to be significantly higher 
in the lateral patient position versus supine (p < 0.01) and in the posterior placentas versus the anterior placentas 
(p = 0.01). These results were more pronounced compared to when patient position (p = 0.01) or placental posi-
tion (p = 0.04) alone was included in the analysis.
Figure 1. Box and whisker plot of global placental perfusion of pregnancies with fetal CHD and healthy 
pregnancies. When controlling for GA, there was a significant difference in global perfusion between CHD and 
controls (p < 0.01).
Figure 2. (a) Scatter plot of global placental perfusion against GA, including only the single or the first scan 
data. Only pregnancies with fetal CHD demonstrated a significant correlation between global placental 
perfusion and GA (r = −0.67, p < 0.01). (b) Two-time-point global perfusion data from seven subjects who 
received MRI scans twice on different days (first and second fetal MRI), with a dotted line connecting the two 
data points within each subject. The slope of the connecting line is akin to that of linear regression line of each 
subject group illustrated in (a).
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Regional placental perfusion measures. The coefficient of variation of the segmented placental perfu-
sion that represents spatial variation of regional perfusion, was found to be 0.62 ± 0.20 in pregnancies with fetal 
CHD and 0.58 ± 0.10 in healthy pregnancies (see Fig. 4). There was no statistically significant difference in the 
coefficient of variation between the two groups when controlling for GA (p = 0.50). Again, however, the scatter 
plot (Fig. 5a) showed a close association of the coefficient of variation and GA in pregnancies with fetal CHD 
only (fetal CHD: r = 0.53, p = 0.03 vs controls: r = 0.11, p = 0.55). With the exception of the outlier at GA of 35 
weeks, fetal CHD showed an even higher correlation with GA. While global placental perfusion decreased with 
advancing GA in pregnancies with fetal CHD, regional perfusion variation increased with advancing GA in this 
group. The slope of the linear regression line was 0.02/week for CHD and 0.00/week for controls. Figure 5b shows 
data from seven subjects who underwent two fetal MRI scans. The slope between the two data points within each 
subject was 0.05, 0.04, and 0.00/week for the three pregnant women with fetal CHD and was −0.01, 0.01, 0.00, 
and 0.00/week for the four healthy controls respectively. Except for the slope of 0.00/week in fetal CHD, these 
slopes from both fetal CHD and controls showed a similarity to the regression lines of their own groups. Unlike 
global placental perfusion, there was no significant difference in regional variation between lateral and supine 
patient positions or between anterior and posterior placentas when controlling for GA, and thus patient position 
and placental position were not included in this analysis.
Figure 6 contains the ASL images of the first and follow-up scans from one representative pregnant patient 
complicated by fetal CHD (diagnosis: HLHS) in the selected slice locations. T2-weighted anatomical images on 
the corresponding slice locations are also displayed as a reference. The ASL images demonstrate that the ASL sig-
nal in the placenta was more homogeneous in the first fetal MRI scan compared to the follow-up scan, although 
the first scan already started to show mild lobulated patterns on ASL images. This lobulation on the ASL images 
became more conspicuous in the follow-up MRI scan; while the lobules contained most of the signal intensity, the 
regions outside the lobules suffered from substantial signal reduction. Similarly, it can be observed that lobulation 
was also present on the anatomical images, but not as dramatic as seen on the ASL images.
Figure 3. Global placental perfusion stratified on the basis of the patient position during the fetal MRI. 
(a) Lateral position: Although similar correlations are noted as those observed in the overall cohort, global 
perfusion in healthy pregnancies demonstrated even more consistent global perfusion across GA (r = −0.09, 
p = 0.74). (b) Supine position: Healthy controls showed a decreasing trend in global perfusion with advancing 
GA (r = −0.43, p = 0.09). (c) Healthy control data of lateral and supine patient positions are compared side-by-
side, showing a significant difference in global placental perfusion (p < 0.01).
Figure 4. Box and whisker plot of coefficient of variation (SD/mean) of segmented placental perfusion of 
pregnancies with fetal CHD and healthy pregnancies. No significant difference between the two groups was 
found when controlling for GA (p = 0.50).
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Discussion
In this study, we successfully demonstrated non-invasive placental perfusion quantification in 17 pregnant 
women whose fetuses were diagnosed with CHD and 31 healthy pregnant women using 3D VSASL MRI. We 
analyzed global perfusion and regional perfusion variation as a function of GA, and reported that changes in 
Figure 5. (a) Scatter plot of the coefficient of variation of segmented placental perfusion and GA, using the 
single or first scan data. Significant correlation between coefficient of variation and GA was found only in 
pregnancies complicated by fetal CHD (r = 0.53, p = 0.03). (b) Data from subjects who received two MRI scans, 
with a dotted line connecting the two data points within each subject. The slope of each subject is similar to that 
of the linear regression line from its own group shown in (a) except for one subject with fetal CHD.
Figure 6. ASL and anatomical MR images of a pregnant woman with fetal CHD (diagnosis: HLHS) in the 
first (GA: 29 weeks) and follow-up (GA: 34 weeks) MRI scans. The placenta is delineated with the dotted line 
on each image. In the follow-up scan, ASL signal decreased in the regions outside lobules within the placenta, 
leading to increased regional variation of placental perfusion.
www.nature.com/scientificreports/
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placental perfusion were significantly related to advancing GA in CHD fetuses, but not in healthy controls. In 
pregnancies complicated by fetal CHD, global placental perfusion significantly decreased and regional variation 
of placental perfusion significantly increased with advancing GA. These findings may be beneficial for detection 
of early functional placental perturbations in fetal CHD. In addition, global placental perfusion was higher in 
pregnant women studied in the lateral patient position versus supine during the fetal MRI and in women with the 
posterior placentas versus the anterior placentas. To the best of our knowledge, this is the first study that demon-
strates perfusion imaging of the whole placenta in vivo, the first study that utilizes VSASL in the placenta, and 
the first to provide evidence of second and third trimester placental perfusion differences between pregnancies 
complicated with fetal CHD and healthy pregnancies.
The labeling method of VSASL has several advantages for placental imaging compared to conventional ASL 
techniques such as pulsed ASL (PASL)19,20 or pseudocontinuous ASL (PCASL)21. First, VSASL is well suited for 
organs like the placenta that have large intravascular space (i.e. small extravascular). Conventional ASL schemes 
rely on the water being extracted from blood and being trapped in tissue with a long mean transit time due to 
large extravascular space in most of human tissues, similar to the microsphere technique. With these methods, 
significant ASL quantification errors can occur for the placenta where water exchange between blood and tissue 
is limited due to its relatively small extravascular space. In contrast, VSASL requires no water exchange because 
there is no need for a long post-labeling delay afforded by nominally zero arterial transit delay, and therefore 
VSASL can be successfully applied in such tissue types. This has been demonstrated previously in the lung, which 
is another human organ with short mean transit time22. Second, spatially non-selective labeling of VSASL is 
highly beneficial for placental ASL. The arterial blood path from the iliac artery to the uterine artery, which is the 
major route for the arterial blood supply to the utero-placental circulation, is extremely tortuous. Furthermore, 
there are other contributions to the placental circulation such as ovarian blood flow, which adds up to 15% of the 
total placental perfusion23. With PCASL, it may not be feasible to find a single labeling plane that captures all of 
the feeding arteries unless the labeling plane is placed in the descending aorta, which in turn would be far from 
the placenta, leading to significant SNR reduction. In addition, even delineating a suboptimal labeling plane in 
each subject would be very time-consuming or may require MR angiography prior to the ASL scan. PASL, on 
the other hand, is also not optimal for placental ASL because the feeding arteries needed for labeling are likely 
to be included in the target imaging slab, leading to compromised labeling. While these limitations of labeling 
efficiency may be resolved and are less problematic in single-slice imaging, single slice imaging in turn, limits its 
clinical use. For these reasons, whole-placenta ASL imaging may be achievable only with VSASL among current 
ASL techniques.
Mean global placental perfusion measured in normal pregnancies using VSASL in our study was found to be 
188 ml/100 g/min (207 and 171 ml/100 g/min in the lateral and supine positions respectively) and it was consistent 
across GA, which corroborates previous studies. Placental ASL was first reported almost twenty years ago from 
a group that published three different studies using presumably the same imaging sequence based on PASL11–13. 
Gowland et al. demonstrated placental ASL with an average perfusion value of 176 ml/100 g/min in normal preg-
nancies (n = 16) and showed no correlation between placental perfusion and GA11. Duncan et al. reported pla-
cental perfusion of 209 ml/100 g/min in normal pregnant women (n = 45) with no correlation with GA12. Francis 
et al. showed a histogram of pixel fraction of placental perfusion that ranged between 0 and 1000 ml/100 g/min in 
healthy pregnancies (n = 6)13. Despite the small sample size, these are comparable to our measurements. Patient 
positioning was not taken into account in these studies. Recently, Derwig et al. reported placental ASL using a 
PASL technique more optimized for humans, but presented an analysis of ASL signal only, without absolute per-
fusion quantification14.
Our results are also comparable to reported values of placental blood flow acquired via Doppler sonogra-
phy. Doppler sonography quantifies volumetric blood flow (in ml/min) by measuring vessel diameter and mean 
velocity of blood flow. Flo et al.24 and Rigano et al.25 reported measurements of volume blood flow in the uterine 
arteries of normal pregnant women throughout the second half of pregnancy and both groups demonstrated a 
significant increase of uterine blood flow during this period of pregnancy, showing good agreement between each 
other. Uterine blood flow in the unit of ml/100 g/min can be estimated by dividing the volumetric blood flow 
by placental weight that was reported in ref.26. Based on these published data, we estimated that uterine blood 
flow normalized by placental weight to decrease from 137 to 104 ml/100 g/min and from 105 to 83 ml/100 g/min 
during the second half of pregnancy based on refs24,25, respectively. Likewise, the contribution of umbilical artery 
flow to placental perfusion in normal pregnant women was estimated in the same manner and was found to be 
rather consistent over GA with the perfusion value of approximately 40 ml/100 g/min27–29. Given that perfusion 
measurement with VSASL includes both contributions of uterine and umbilical arteries, our results should be 
compared with the sum of these two perfusion values, which was slightly lower than that of our healthy controls. 
However, our measurement with VSASL may have also included contributions of ovarian arteries and other col-
lateral vessels that may contribute to the placental circulation.
We further analyzed placental perfusion measures of pregnant women studied in the lateral and supine posi-
tions during the fetal MRI, and demonstrated a significant difference in placental perfusion between the two 
patient positions. It has been recommended that the supine position of pregnant women should be avoided for 
lengthy fetal MRI studies because maternal blood circulation is likely disturbed by compression of the inferior 
vena cava due to the mass effect of the gravid uterus18. Our data support that this effect may also influence placen-
tal perfusion. In our healthy controls, placental perfusion was not only significantly lower in the supine position 
compared to the lateral position, but while perfusion was stable in the lateral position, there was a progressive 
decrease in perfusion with advancing gestation in the supine position, likely due to increasing weight of the gravid 
uterus over time. These findings recommend the use of lateral decubitus position for the measurement of placen-
tal perfusion to avoid the mass effect of the gravid uterus. In addition, placental perfusion was found to be signif-
icantly higher in the posterior placentas versus anterior. Only one previous study has examined the relationship 
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between anterior and posterior placentas, they showed no significant difference placental position and pulsatility 
index of the uterine arteries30. However, it is important to note that pulsatility index may not be correlated with 
placental perfusion. These intriguing preliminary findings in our study need further validation on a larger cohort 
which is currently underway.
Our findings demonstrated that both global placental perfusion and regional variation of placental perfusion 
in fetal CHD were significantly different compared to controls. Similar to the human brain, heart, and kidney, 
the placenta may have an autoregulatory mechanism to maintain optimal perfusion9. The early increased global 
placental perfusion in fetal CHD observed in our study may represent an attempt to compensate for the perfusion 
deficit in the fetal circulation, which may eventually fail. On the other hand, reduction of placental perfusion 
later in pregnancy among fetuses with CHD often revealed a lobulated pattern on the perfusion maps of our data. 
As previously observed on T2-weighted images31,32, these lobules may correspond to cotyledons of the placenta 
(i.e. fetal compartment) and the regions outside the lobules correspond to the septa, which represent parts of the 
decidua (i.e. maternal compartment) extended toward the intervillous space. Reduced perfusion in the maternal 
compartment of the placenta may suggest that the balance of placental perfusion is adjusted in response to an 
abnormal fetal circulation, and more blood flow is directed to the fetus rather than the placental tissue itself. On 
T2-weighted images, visible lobulations later in pregnancy may be explained by the T2 differences between blood 
and placental tissue33 given that blood volume, which is likely correlated with perfusion, may also decrease in the 
maternal compartment. Interestingly, several CHD cases in our study exhibited placental lobulation patterns on 
ASL images that were not evident on T2-weighed images, suggesting that functional lobulations in the placenta 
may be detected by ASL images prior to the anatomic changes detected on T2-weighted images. These global 
and/or regional perfusion changes across GA may have the potential for developing a future early biomarker 
of placental dysfunction in fetal CHD. Once placental dysfunction is detected before placental abnormalities 
become irreversible, there will be new, currently unavailable opportunities for potential treatment and preventive 
strategies. Ongoing studies are needed to address this important research question.
Placental ASL may play an important role in investigating potential causes and morbidities associated with 
CHD. Our findings suggest that fetal CHD is associated with placental dysfunction that is evident in the second 
and third trimester of pregnancy. This is corroborated by prior studies that demonstrated reduced oxygenation 
in the umbilical vein and the placenta or an increased incidence of placental insufficiency (such as FGR and 
preeclampsia), in the setting of fetal CHD34–37. Huhta and Linask suggested that placentation and fetal heart 
development may be affected by common environmental factors that predispose to malformation5,6. In-vivo mon-
itoring of the placenta using ASL early in pregnancy may help elucidate the shared etiology of CHD and placental 
dysfunction.
Although there are a number of strengths in our study, the limitations deserve mention. First, our prelimi-
nary data come from a relatively small sample of healthy and high-risk pregnant populations, which included 
a heterogeneous cohort of CHD diagnostic groups. We did not find a significant difference in placental per-
fusion between single-ventricle and two-ventricle diseases or between cyanotic and non-cyanotic CHD (data 
not shown). Nonetheless, a larger sample size is warranted to confirm these initial findings. Second, placental 
perfusion measured using VSASL included contributions of both maternal and fetal circulation. Although this 
may not necessarily be a limitation, it would be of interest to determine which contribution (fetal vs maternal) 
represents the major source of altered placental perfusion in this high-risk population. Such investigations may be 
feasible with the development of new imaging schemes that measure each contribution separately. These studies 
are currently underway.
In conclusion we report for the first time, in-vivo whole-placenta perfusion imaging in pregnant women using 
VSASL-MRI. Our preliminary results show that global placental perfusion decreases and regional variation of 
placental perfusion increases with advancing GA in CHD fetuses only. We also report that global placental per-
fusion is significantly higher in the lateral patient position versus supine during the fetal MRI and in pregnant 
mothers with the posterior placentas versus anterior. Our preliminary findings suggest that placental perfusion is 
altered in pregnancies diagnosed with fetal CHD. The predictive value of these initial placental perfusion altera-
tions on pregnancy and CHD outcomes are unknown and currently under study.
Materials and Methods
Study population. In the context of a prospective observational study, 18 pregnant women with a diagnosis 
of fetal CHD confirmed by echocardiography were recruited from the Fetal Cardiac Clinic at Children’s National 
Medical Center. Thirty-two control fetuses were studied from healthy pregnant volunteers with a normal pre-
natal history, and normal screening laboratory/ultrasound studies. Exclusion criteria for both healthy fetuses 
and fetuses diagnosed with CHD included: multiple gestation pregnancies, congenital infection, documented 
chromosomal abnormalities, and/or CNS and extra-CNS anomalies. Pregnant women who were unable to enter 
the MRI scanner for health (physical or psychological) reasons, or who did not meet standard criteria for MRI 
safety, such as the presence of non-removable ferromagnetic material were also excluded from the study. Enrolled 
pregnant women completed a fetal MRI study during the second or third trimester of pregnancy. A small subset 
of the study participants received two fetal MRI studies. This study was approved by the institutional review board 
of Children’s National Medical Center and written informed consent was obtained from each subject. All experi-
ments were performed in accordance with the institutional guidelines and regulations.
Fetal MRI. All MR imaging was performed on a GE MR450 1.5 T scanner using an 8-channel cardiac array 
coil. Pregnant subjects were scanned either in the supine or lateral decubitus position depending on the patient 
size and their preference. In each study, 2D T2-weighted single-shot fast spin echo imaging was performed for 
anatomical imaging and 3D VSASL was performed for the measurement of placental perfusion. This approach 
of placental perfusion imaging has been previously described and demonstrated to be superior in comparison 
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with conventional ASL in our preliminary study15. T2-weighted imaging utilized the scan parameters of TR/
TE = 1200/160 ms, matrix size = 256 × 192, FOV = 36–42 cm, and slice thickness = 4 mm with 40–60 slices. 
In VSASL, velocity-selective labeling was achieved using dual hyperbolic secant (sech) inversion with a cutoff 
velocity = 2 cm/s and TI = 1600 ms. Image acquisition in VSASL was performed using fast-spin-echo 3D stack of 
spirals with 8 interleaves, TR/TE = 3000/10 ms, in-plane matrix size = 64 × 64 over FOV = 36–40 cm, and slice 
thickness = 4 mm with 36–44 slices. Background suppression was achieved using one saturation and four sech 
inversion pulses. VSASL scan was composed of five pairs of control/labeled imaging followed by proton-density 
imaging, leading to total scan time of 4:30 min.
Global placental perfusion measures. We used Buxton’s general kinetic model to quantify placental per-
fusion from ASL difference images and proton-density images38. Based on this model, placental perfusion (in 
ml/100 g/min) was calculated using the equation of [6000·λ·(SIcontrol − SIlabeled)]/[TI·SIPD·exp(−TI/T1,blood)] where 
λ is the tissue-blood partition coefficient (0.9 ml/g), SIcontrol and SIlabeled are the signal intensities in the control 
and labeled images, TI is the time between labeling and imaging, SIPD is the signal intensity of the proton density 
image, and T1,blood is T1 of blood (1.350 sec at 1.5 T)10. For calculating global placental perfusion, we manually 
delineated the placenta on each slice of the proton density images and averaged perfusion of all voxels within 
the whole placenta of each subject. The structural images were also used as a reference when the contrast of the 
placenta on proton density images was not clear.
Regional placental perfusion measures. We postulated that impaired global perfusion in the compro-
mised placenta would not appear as a global scaling effect, but rather be driven by regional perfusion reductions 
in the placenta. This can be predicted based on the typical lobulated pattern of the vascular development in the 
placenta, which also becomes evident on T2-weighted MR images with advanced GA or pathology31,32. To evalu-
ate regional variation of placental perfusion, we extended our global perfusion analysis as follows. After the whole 
placenta was segmented for each subject, the placenta on each image slice was divided into multiple equal-sized 
segments, with the segments on the boundary of the placenta discarded (see Fig. 7). We used the segment size of 
3 × 3 voxels from 128 × 128 interpolated ASL images, leading to segment area of 8.4–9.4 mm2 depending on FOV 
used for each subject. We measured mean perfusion within each segment and calculated a coefficient of variation 
(i.e. standard deviation divided by mean) of segmented perfusion measurements for each subject.
Statistical analysis. Descriptive statistics were used to characterize our cohort. We used a Wilcoxon 
rank-sum test to compare GA and maternal age and a chi-squared test to compare fetal sex, between pregnan-
cies with fetal CHD and healthy pregnancies. To determine the difference in global/regional placental perfusion 
between fetal CHD and controls, we used multiple linear regression analysis. We also calculated Pearson’s corre-
lation coefficients and corresponding p values to examine the correlation between placental perfusion and GA. 
We used a significance level of 0.05 for all tests.
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